Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Azman

Showing results (191-200 of 204) with videos related to

Pageof 21
Sort By:
The Lancet Regional Health. Europe|December 7, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based studyMaría-Eugenia Zaballa, Javier Perez-Saez, Carlos de Mestral, et al.
The Lancet. Infectious Diseases|January 21, 2024
Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control studyEspoir Bwenge Malembaka, Patrick Musole Bugeme, Chloe Hutchins, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based studyKirsten E Wiens, Pinyi Nyimol Mawien, John Rumunu, et al.
Nature|February 14, 2019
Publisher Correction: Genomic insights into the 2016-2017 cholera epidemic in YemenFrançois-Xavier Weill, Daryl Domman, Elisabeth Njamkepo, et al.
Nature|January 4, 2019
Genomic insights into the 2016-2017 cholera epidemic in YemenFrançois-Xavier Weill, Daryl Domman, Elisabeth Njamkepo, et al.
The American Journal of Tropical Medicine and Hygiene|September 3, 2024
Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance SummitAndrea C Carcelen, Alex C Kong, Saki Takahashi, et al.
Emerging Infectious Diseases|December 11, 2022
Comparison of COVID-19 Pandemic Waves in 10 Countries in Southern Africa, 2020-2021Joshua Smith-Sreen, Bridget Miller, Alinune N Kabaghe, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Dynamics and significance of the antibody response to SARS-CoV-2 infectionAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
Science Immunology|October 9, 2020
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
Lancet (London, England)|December 22, 2025
Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort studyEmmanuel Hasivirwe Vakaniaki, Isaac Barhishindi, Ange Mubiala, et al.
Pageof 21

Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
The Lancet Regional Health. Europe|December 7, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based studyMaría-Eugenia Zaballa, Javier Perez-Saez, Carlos de Mestral, et al.
The Lancet. Infectious Diseases|January 21, 2024
Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control studyEspoir Bwenge Malembaka, Patrick Musole Bugeme, Chloe Hutchins, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based studyKirsten E Wiens, Pinyi Nyimol Mawien, John Rumunu, et al.
Nature|February 14, 2019
Publisher Correction: Genomic insights into the 2016-2017 cholera epidemic in YemenFrançois-Xavier Weill, Daryl Domman, Elisabeth Njamkepo, et al.
Nature|January 4, 2019
Genomic insights into the 2016-2017 cholera epidemic in YemenFrançois-Xavier Weill, Daryl Domman, Elisabeth Njamkepo, et al.
The American Journal of Tropical Medicine and Hygiene|September 3, 2024
Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance SummitAndrea C Carcelen, Alex C Kong, Saki Takahashi, et al.
Emerging Infectious Diseases|December 11, 2022
Comparison of COVID-19 Pandemic Waves in 10 Countries in Southern Africa, 2020-2021Joshua Smith-Sreen, Bridget Miller, Alinune N Kabaghe, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Dynamics and significance of the antibody response to SARS-CoV-2 infectionAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
Science Immunology|October 9, 2020
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
Lancet (London, England)|December 22, 2025
Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort studyEmmanuel Hasivirwe Vakaniaki, Isaac Barhishindi, Ange Mubiala, et al.
Pageof 21